MOFETYL 250MG TABLET

Mofetyl 250 mg Tablet is an immunosuppressant with an active ingredient known as Mycophenolate mofetil. It is part of the inosine monophosphate dehydrogenase (IMPDH) inhibitor class. The medicine is prescribed to avoid organ rejection in patients who have had one of their organs (such as heart, kidney transplantation, or liver). It is part of a combination treatment that includes other immunosuppressive medicines.
The use of this drug is not recommended during pregnancy because of the risk of miscarriage or congenital disabilities. It is not recommended during pregnancy unless there are no other alternatives and the benefits outweigh any risks. Women who are pregnant should take effective contraceptives while using this tablet to avoid the onset of pregnancy. Live vaccines shouldn’t be administered when a person is taking a 250mg Mofetyl Tablet due to decreased effectiveness and the possibility of contracting infection. People taking this drug are not allowed to donate blood during treatment and, at minimum, six weeks after having stopped treatment. It is a way to ensure that the medication has been completely removed from the body before donating blood.
It is recommended not to take this drug when allergic to the medication or other ingredients. Inform your doctor about heart or liver disease before starting the treatment. Because this drug weakens the body’s immune system, it increases the risk of developing skin cancer. People should reduce their exposure to UV (UV) radiation. Consult your physician immediately in case of skin bruising on your body, fever, unresolved fatigue, dizziness, discoloration of the skin or eyes, vision impairment, decreased output of urine, or seizures following taking this medication. Mofetyl 250 mg Tablet is an immunosuppressive drug. It can affect the infant’s developing immune system and should not be used while breastfeeding. In certain instances, alternatives to medications that have an improved safety profile when breastfeeding could be thought of as.